Last week, the FDA added new heart health risk information to mRNA vaccines’ fact sheets. In addition, the U.S. seized unauthorized COVID-19 drugs en route from Bangladesh and India to Mexico. Please see details for these and other supply chain developments below:
- On June 23, the Wall Street Journal reported that the U.S. government had seized at U.S. airports unauthorized versions of the COVID-19 treatment remdesivir, which were en route from Bangladesh and India to Mexico.
- On June 24, the FDA issued an emergency use authorization (EUA) for Actemra (tocilizumab) for the treatment of COVID-19 in hospitalized adults and pediatric patients (2 years of age and older) who are receiving systemic corticosteroids and require supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).
- On June 24, President Biden announced that 66 percent of all American adults have received at least one shot of COVID-19 vaccine, including over 150 million Americans fully vaccinated.
- On June 25, the FDA announced revisions to the patient and provider fact sheets for the Moderna and Pfizer/BioNTech COVID-19 vaccines to include information regarding risks of myocarditis (inflammation of the heart muscle) and pericarditis (inflammation of the tissue surrounding the heart) following vaccination.
[View source.]
